Stocktoria
Design Therapeutics, Inc. DSGN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-03-26
Chart by TradingView
1/9
Piotroski F — financial health
15.76
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $0 | $0 | — | — | — |
| Operating income | -$79.5M | -$62.4M | -$78.2M | -$67.6M | -$35.8M |
| Net income | -$69.8M | -$49.6M | -$66.9M | -$63.3M | -$35.5M |
| Operating cash flow | -$54.4M | -$43.1M | -$58.6M | -$51.3M | -$29.4M |
| Free cash flow | -$54.6M | -$43.4M | -$58.8M | -$52.2M | -$30.9M |
| Total assets | $226.2M | $252.1M | $289.6M | $341.1M | $390.6M |
| Total liabilities | $13.7M | $10.0M | $12.0M | $13.8M | $8.4M |
| Shareholders' equity | $212.5M | $242.1M | $277.7M | $327.3M | $382.1M |
| Ratios | |||||
| Return on assets | -30.9% | -19.7% | -23.1% | -18.6% | -9.1% |
| Return on equity | -32.8% | -20.5% | -24.1% | -19.3% | -9.3% |
| Current ratio | 17.14 | 29.31 | 29.58 | 31.10 | 72.96 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 2,722,754 | $29.0M |
| RENAISSANCE TECHNOLOGIES LLC | 408,200 | $4.3M |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 15.76 (safe)
- Working capital / assets 0.932
- Retained earnings / assets -1.313
- EBIT / assets -0.351
- Equity / liabilities 15.511
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001807120 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.